The Rising Prevalence of Chronic Diseases Such as Cardiovascular Disease Across Europe is Driving the Europe Medical Devices Market

The rising prevalence of chronic diseases such as cardiovascular disease across Europe is significantly increasing the demand for advanced diagnostic and therapeutic medical devices. Chronic conditions require continuous monitoring, early detection, and long-term disease management, which has intensified the need for sophisticated healthcare technologies. Hospitals and healthcare providers are increasingly adopting advanced imaging systems, cardiac monitoring devices, glucose monitoring systems, and minimally invasive treatment technologies to improve diagnostic accuracy and patient outcomes. In the case of cardiovascular disorders, the growing number of patients with conditions such as heart failure, coronary artery disease, and arrhythmias has accelerated the adoption of medical devices, including implantable cardiac monitors, pacemakers, and advanced catheter-based treatment systems.

Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-medical-devices-market

Data Bridge Market Research analyses that the Europe Medical Devices Market is expected to reach USD 425.73 billion by 2033 from USD 259.29 billion in 2025, growing with a CAGR of 6.4% in the forecast period of 2026 to 2033.

Key Findings of the Study

The Growing Aging Population in European Countries is Significantly Increasing the Need for Medical Devices Used in Monitoring and Long-Term Care

The growing aging population across European countries is significantly increasing the demand for medical devices used in monitoring and long-term care. A larger proportion of the population in the region is entering older age groups that are more susceptible to chronic conditions such as cardiovascular diseases, diabetes, respiratory disorders, and mobility limitations. Elderly patients typically require continuous health monitoring, early disease detection, and long-term management of multiple medical conditions, which drives the adoption of advanced medical devices designed for home care, remote monitoring, and assisted living environments. Devices such as cardiac monitoring systems, respiratory support equipment, and mobility assistance technologies are increasingly utilized to help healthcare providers track patient health in real time and intervene promptly when complications arise. Furthermore, healthcare providers and governments are also focusing on improving the quality of life for aging populations by integrating remote patient monitoring systems. Consequently, the demographic transition toward an older population is becoming a major structural driver supporting sustained demand for medical devices across Europe.

Report Scope and Market Segmentation

Segment Analysis

The Europe medical devices market is segmented into four notable segments based on product type, patient population, end user, and distribution channel.

• On the basis of product type, Europe medical device market is segmented into laboratory devices, diagnostic imaging devices, cardiovascular devices, orthopedic devices, respiratory devices, endoscopy devices, neurology devices, dental devices, ophthalmology devices, aesthetic devices, and other medical devices.

In 2026, the laboratory devices is expected to dominate the Europe medical devices market

The laboratory devices segment is expected to dominate the market in 2026, with a 22.95% market share, owing to its critical role in supporting diagnostic testing, clinical research, and disease monitoring across healthcare facilities. The increasing prevalence of chronic and infectious diseases has significantly driven the demand for laboratory equipment such as analyzers, diagnostic systems, and testing instruments.

• On the basis of patient population, the Europe medical device market is segmented into adult, geriatric, and pediatric.

In 2026, the adult segment is expected to dominate the Europe medical devices market

The adult segment is projected to dominate the market with in 2026, with a 61.26% market share due to higher prevalence of chronic diseases and medical conditions among the adult population. Adults are more likely to require frequent diagnostic tests, medical treatments, and monitoring procedures, which drives significant demand for healthcare services and medical devices. Additionally, lifestyle-related disorders such as cardiovascular diseases, diabetes, and obesity are more common in adults, further increasing the need for advanced medical interventions and diagnostic solutions.

• On the basis of end user, Europe medical device market is segmented into hospitals, clinics, diagnostic centers, imaging centers, academic & research institutes, and others. The hospitals segment is estimated to dominate the market in 2026 with a share of 41.68% due to its central role in delivering comprehensive healthcare services and handling a large volume of diagnostic and treatment procedures. Hospitals are equipped with advanced medical technologies and specialized healthcare professionals, enabling them to manage complex medical conditions and perform a wide range of clinical procedures. Additionally, the growing number of hospital admissions, rising prevalence of chronic diseases, and increasing demand for advanced diagnostic and treatment solutions have significantly contributed to the segment’s dominance.
• On the basis of distribution channel, the Europe medical device market is segmented into direct tender, third-party distributors, retail sales, and others. The direct tender segment is expected to dominate the market in 2026, with a share of 44.76% due to the widespread procurement practices adopted by hospitals, government healthcare institutions, and large medical facilities. Direct tendering enables healthcare providers to procure medical equipment and devices in bulk directly from manufacturers or authorized suppliers, ensuring better pricing, quality assurance, and transparent procurement processes. Additionally, government healthcare projects and public hospital networks often rely on tender-based purchasing systems to maintain cost efficiency and regulatory compliance.

Major Players

Data Bridge Market Research analyzes some of the major market players operating in the market are F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthcare (Germany), Hitachi Ltd. (Japan), Terumo Corporation (Japan), Olympus Corporation (Japan), Hoya Corporation (Japan), Nipro Corporation (Japan), Sysmex Corporation (Japan), General Electric Company (U.S.), Koninklijke Philips N.V. (Netherlands).

Market Developments

• In August 2025, Agfa-Gevaert NV signed a new 3 year revolving credit facility of 180 million euro. The new facility will run until August 1, 2028. This new revolving credit facility will be used for working capital and general corporate purposes. It will replace the existing revolving credit facility that would have expired May 30, 2026. The new revolving credit facility has been arranged by a club of 4 financial institutions: BNP Paribas Fortis SA/NV, KBC Bank NV, Belfius Bank SA/NV, and ING Belgium SA/NV
• In May 2025, Mindray launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform, this advanced system provides industry-first innovations in ultrasound-integrated hemodynamic assessment and cable-lite patient monitoring workflow, redefining the bedside monitor as a dynamic hub of precision medicine.
• In September 2021, Mindray launched the new MC-80 Automated Digital Cell Morphology Analyzer, a revolutionary cell morphology system that provides more clarity, more intelligence, and more productivity for morphological analysis. Combining MC-80, Mindray’s hematology solution, will revolutionize the high-end hematology segment.
• In December 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced the completion of its acquisition of a 75% stake in Germany-based DiaSys Diagnostic Systems GmbH (“DiaSys”). Upon completion, DiaSys is now recognized as a majority-owned subsidiary of Mindray.
• In March 2026, Planmed Oy earned CE MDR (Medical Device Regulation) certification for its Planmed Clarity+ mammography product line. Planmed Clarity+ is the newest addition to the Planmed mammography family. The Planmed Clarity+ product line is designed to provide superior image quality, optimized workflow, and patient comfort in mammography

Regional Analysis

Geographically, the country covered in the Europe Medical Devices market report is Germany, U.K., France, Italy, Spain, Russia, Turkey, Netherlands, Norway, Finland, Denmark, Sweden, Poland, Switzerland, Belgium, Rest of Europe.

As per Data Bridge Market Research analysis:

Germany is the dominant country in the Europe medical devices market

Germany emerged as the largest revenue-generating region in the Europe medical devices market, accounting for 18.31% share in 2025, supported by its well-established healthcare infrastructure, strong presence of leading medical device manufacturers, and high healthcare expenditure. The country benefits from a large network of hospitals, research institutions, and diagnostic centers that drive the demand for advanced medical technologies.

Poland is estimated to be the fastest-growing country in the Europe Medical Devices market

Poland is expected to be the fastest-growing region during the forecast period growing with a CAGR of 8.4%, driven by increasing healthcare investments, expanding medical infrastructure, and rising demand for advanced medical technologies. The country is witnessing significant improvements in its healthcare system, supported by government initiatives aimed at modernizing hospitals and diagnostic facilities. Additionally, the growing prevalence of chronic diseases, rising healthcare awareness, and increasing adoption of modern diagnostic and treatment devices are contributing to market expansion.

For more detailed information about Europe medical devices market click here – https://www.databridgemarketresearch.com/reports/europe-medical-devices-market